ID: ALA5280430

Max Phase: Preclinical

Molecular Formula: C20H22N2O5S2

Molecular Weight: 434.54

Associated Items:

Representations

Canonical SMILES:  CCc1ccc(-c2cc(-c3ccc(S(=O)(=O)N[C@H](C(=O)O)C(C)C)cc3)no2)s1

Standard InChI:  InChI=1S/C20H22N2O5S2/c1-4-14-7-10-18(28-14)17-11-16(21-27-17)13-5-8-15(9-6-13)29(25,26)22-19(12(2)3)20(23)24/h5-12,19,22H,4H2,1-3H3,(H,23,24)/t19-/m0/s1

Standard InChI Key:  YUKZMFUVSSRXAN-IBGZPJMESA-N

Associated Targets(Human)

Matrix metalloproteinase-2 6627 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matrix metalloproteinase 9 6779 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matrix metalloproteinase 12 1130 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 434.54Molecular Weight (Monoisotopic): 434.0970AlogP: 4.02#Rotatable Bonds: 8
Polar Surface Area: 109.50Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.10CX Basic pKa: CX LogP: 4.57CX LogD: 1.11
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.55Np Likeness Score: -1.58

References

1. Baidya SK, Amin SA, Jha T..  (2021)  Outline of gelatinase inhibitors as anti-cancer agents: A patent mini-review for 2010-present.,  213  [PMID:33279289] [10.1016/j.ejmech.2020.113044]

Source